NAC for Weight Loss: What Randomized Human Trials Show

NAC is not a proven weight-loss supplement. Two randomized trials in adults with obesity found interesting changes in insulin resistance, inflammation and adipose-tissue biology, but neither demonstrated meaningful improvement in body measurements.

NAC and weight loss at a glance

Claim	Human evidence
Weight loss	Not demonstrated.
Waist / anthropometric improvement	No significant effect in the small randomized trials.
Insulin resistance	Some positive short-term biomarker data.
Adipose senescence	Interesting mechanistic signal.
“Fat burning” / metabolism boost	Not established.

The 2023 randomized obesity trial

A randomized double-blind trial enrolled 40 adults with obesity who were preparing for bariatric surgery. Twenty received NAC 600 mg/day and 20 received placebo for four weeks.

NAC improved several metabolic and inflammatory measures, including fasting glucose, insulin, HOMA-IR, IL-6 and hs-CRP. Visceral adipose tissue also showed reductions in senescence-related markers.

But the outcome most relevant to the keyword “weight loss” was negative: anthropometric measures did not significantly improve.

The 2024 thermogenesis/thyroid-pathway trial

A second randomized double-blind trial included 43 adults with obesity and used 600 mg/day NAC for eight weeks.

The researchers examined UCP1 and thyroid-related gene expression in visceral adipose tissue. NAC significantly reduced DIO3 expression, but other gene changes were not statistically significant after adjustment.

Most importantly, the study again found no significant effect on anthropometric factors or serum thyroid-hormone levels.

Why metabolic improvements do not equal weight loss

Insulin resistance, inflammation, oxidative stress and adipose senescence are relevant to obesity biology. Improving one of those pathways can be scientifically meaningful without causing enough energy-balance change to reduce body weight.

This is a common supplement-marketing error: a mechanistic biomarker improves, then the product is advertised as a “fat burner.” The NAC trials do not support that leap.

Does NAC increase metabolism?

The eight-week trial investigated thyroid-related and thermogenesis-associated genes because those pathways influence energy expenditure.

A change in DIO3 expression alone does not prove that resting metabolic rate increased, that fat oxidation increased enough to matter clinically, or that participants lost weight.

Can NAC improve insulin resistance?

The four-week trial reported favorable changes in insulin and HOMA-IR. That is promising metabolic evidence, but the sample was small and the duration short.

It also does not establish NAC as a treatment for diabetes or metabolic syndrome.

Does GlyNAC cause weight loss?

GlyNAC trials in older adults have included body composition and waist-related outcomes, but the combination uses glycine plus NAC and should not be used to prove NAC-only weight loss.

See GlyNAC benefits for that separate evidence.

What about cravings or emotional eating?

NAC's glutamate effects have prompted research into compulsive and reward-driven behaviors, including a registered open-label pilot for loss-of-control eating. That type of feasibility research does not establish weight loss.

What should drive evidence-based weight management?

For clinically meaningful weight loss, the strongest approaches remain sustained nutrition and activity strategies, appropriately selected anti-obesity medications, and bariatric/metabolic surgery for eligible patients.

NAC can be studied as a metabolic adjunct without being promoted as an alternative to treatments that directly demonstrate weight loss.

Bottom line

Human randomized trials do not support NAC as a weight-loss supplement. They show interesting short-term metabolic and adipose-tissue signals without significant changes in body measurements. In 2026, the correct label is “metabolic research interest,” not “fat burner.”